Clinical Trials Browser

Phase 3 × INDUSTRY × tanezumab × Clear all

NCT02609828 2023-02-16

Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy

Phase 3 Completed

156 enrolled 31 charts

Cancer Pain, Multiple Myeloma